Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 30K | $841K | $28.04 | Nov 10, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals, Inc. | Nov 10, 2022 | 1 | $5.54K | 4 | Nov 14, 2022 | Chief Financial Officer |
MIRM | Mirum Pharmaceuticals, Inc. | May 10, 2022 | 1 | $15.3K | 4 | May 12, 2022 | Chief Financial Officer |
MIRM | Mirum Pharmaceuticals, Inc. | Jan 6, 2022 | 2 | $0 | 4 | Jan 7, 2022 | Chief Financial Officer |
MIRM | Mirum Pharmaceuticals, Inc. | Nov 24, 2021 | 2 | $20.5K | 4 | Nov 29, 2021 | Chief Financial Officer |
MIRM | Mirum Pharmaceuticals, Inc. | Nov 10, 2021 | 1 | $6.19K | 4 | Nov 15, 2021 | Chief Financial Officer |
MIRM | Mirum Pharmaceuticals, Inc. | Sep 29, 2021 | 2 | -$30.3K | 4 | Oct 1, 2021 | Chief Financial Officer |
MIRM | Mirum Pharmaceuticals, Inc. | May 10, 2021 | 1 | $14.3K | 4 | May 12, 2021 | Chief Financial Officer |